For Zepbound-specific dose tracking, see the Zepbound App and Zepbound Side Effect Tracker App pages
TRIUMPH-2 Results in Detail TRIUMPH-2 enrolled 1,152 adults with obesity or overweight and type 2 diabetes, randomized to retatrutide 4mg, 9mg, 12mg, or placebo over 80 weeks a 1:1:1:1 design
It simply helps your skin behave the way it did before rapid weight loss left it behind
When increasing your tirzepatide dose or semaglutide dose , expect the possibility of temporary injection site reactions even if you had none at the lower dose
Semaglutide GLP-1 significantly aids in weight loss but is not a standalone solution for weight management
Systematic adverse event collection would inform risk-benefit assessment and identify any previously unrecognized safety concerns